through industri
creat headwind elanco confid busi
anim health competitor elanco nr withdrew revenu ep
guidanc given uncertainti respect evolv
pandem highlight tidbit interest elan call sell-
side analyst high level express confid anim health
industri busi strategi note headwind
particularli companion anim uncertainti given earli stage
pandem updat address outlook
recent lower estim pt reflect potenti
headwind see would expect substant updat
later next earn call continu view
best-in-class anim health compani hold rate stock
see risk/reward rel balanc said effect crisi
stock give valuation-sensit investor anoth opportun
tidbit interest elan call analyst
companion anim side indic traffic veterinari
clinic stop becom slow given earli stage rapidli
evolv natur pandem difficult quantifi magnitud vet
shutdown companion anim sale account revenu
manag expect acceler telemedicin vet work adapt
telemedicin yet widespread veterinari clinic
well clinic us
seen signific shift altern channel on-line
note major companion anim product avail
food anim side feel good demand protein
asid us cattl market new difficult predict
pandem might impact food anim busi manag
confid busi medium long term driven global
demand anim protein refer livestock sale account
revenu
elan manufactur plant continu oper compani
experienc suppli disrupt manag also indic
pipelin project slow stop note made similar
comment suppli chain manufactur plant activ
attempt factor impact
recent updat model reflect potenti impact demand evolv
pandem lower revenu estim start took
revenu vs guidanc ep vs guidanc
page
valuat risk
pt assum stock trade ebitda similar current
multipl ebitda downsid risk includ lower growth livestock companion
segment lower growth abaxi lower sale key product apoquel cytopoint simparica
consolid custom and/or competitor global econom downturn advers fx trend
upsid risk includ higher growth livestock companion abaxi higher sale apoquel
cytopoint simparica greater contribut new product
compani mention note
gregg gilbert herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express specif
recommend report
analyst compens base upon stock price perform qualiti analysi commun skill
overal revenu profit firm includ invest bank revenu
matter polici practic firm prohibit offer favor research specif
research rate specif target price consider induc receipt busi
compens addit associ person prepar research report prohibit own
secur subject compani
rate price target histori zoeti inc zts-u
creat bluematrix
strh rate system equiti secur
dissemin research
suntrust robinson humphrey strh seek make reason effort provid research report
simultan elig client report avail publish restrict access area
websit elig client request password institut investor corpor
member press may also receiv research via third parti vendor includ thomson reuter
bloomberg factset capit iq addit distribut may done sale personnel via
email fax electron mean regular mail
access third parti vendor research websit http //suntrustlibrari bluematrix com/client/
pleas email research depart
contact strh sale repres
strh rate equiti secur
page
rate rel broader market gener next month unless
buy stock total return expect outperform relev benchmark
hold stock total return expect perform line relev benchmark
next month unless otherwis indic
sell stock total return expect under-perform relev benchmark
next month unless otherwis indic
rate nr strh invest rate opinion stock
coverag suspend cs indic strh rate and/or target price temporarili
suspend due applic regul and/or strh manag discret previous publish
rate target price reli upon
strh analyst price target stock cover unless otherwis indic price
target repres analyst expect stock trade next month unless
otherwis indic analyst believ insuffici valuat driver and/or invest
catalyst deriv posit neg invest view may elect approv strh
research manag assign target price likewis certain stock trade may
exhibit volatil wherebi assign price target would unhelp make invest decis
research manag approv analyst may refrain assign target sub-
legend rate price target histori chart
suntrust robinson humphrey rate distribut
